Matches in Wikidata for { <http://www.wikidata.org/entity/Q66404691> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q66404691 description "clinical trial" @default.
- Q66404691 description "ensayu clínicu" @default.
- Q66404691 description "klinisch onderzoek" @default.
- Q66404691 description "клінічне випробування" @default.
- Q66404691 name "Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib" @default.
- Q66404691 name "Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib" @default.
- Q66404691 type Item @default.
- Q66404691 label "Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib" @default.
- Q66404691 label "Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib" @default.
- Q66404691 prefLabel "Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib" @default.
- Q66404691 prefLabel "Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib" @default.
- Q66404691 P1050 Q66404691-BF9F0389-8CC0-4A62-8D57-71919CB73210 @default.
- Q66404691 P1132 Q66404691-B5A95BF9-D3A7-451C-BBB0-C10BBC3E3DC5 @default.
- Q66404691 P1476 Q66404691-B57858EC-FBDD-49E4-BA0F-AB532847C289 @default.
- Q66404691 P17 Q66404691-C3D8E0C2-9D3D-4C34-B03A-3E0A1E08ACBC @default.
- Q66404691 P2899 Q66404691-D8616233-78E4-4F83-9F50-DF148068685A @default.
- Q66404691 P3098 Q66404691-A6214343-6F2B-4F7B-903E-F45966AA62D5 @default.
- Q66404691 P31 Q66404691-86C88F99-73A1-434D-8C97-FB44A7D32C26 @default.
- Q66404691 P4844 Q66404691-729B9507-BB3D-4B07-83B4-83DBDF93B2D4 @default.
- Q66404691 P580 Q66404691-7B057164-41E0-4BA5-B4E1-8EAE41CADDCE @default.
- Q66404691 P582 Q66404691-748C0937-33A0-424E-8F38-F880263E2AE6 @default.
- Q66404691 P6099 Q66404691-4C163634-822E-4FC6-9F53-716B14EBDE57 @default.
- Q66404691 P8363 Q66404691-ACE1C9DC-8E3C-465C-B8E0-2B7DEB923D01 @default.
- Q66404691 P1050 Q356033 @default.
- Q66404691 P1132 "+100" @default.
- Q66404691 P1476 "A Pilot Study of Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-mutated, Non-Small Cell Lung Cancer (NSCLC) After Treatment With Osimertinib (AZD9291, Tagrisso)" @default.
- Q66404691 P17 Q30 @default.
- Q66404691 P2899 "+18" @default.
- Q66404691 P3098 "NCT02759835" @default.
- Q66404691 P31 Q30612 @default.
- Q66404691 P4844 Q21506464 @default.
- Q66404691 P580 "2016-04-13T00:00:00Z" @default.
- Q66404691 P582 "2021-02-01T00:00:00Z" @default.
- Q66404691 P6099 Q42824440 @default.
- Q66404691 P8363 Q78089383 @default.